HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.
Ramírez A, Boulaiz H, Morata-Tarifa C, Perán M, Jiménez G, Picon-Ruiz M, Agil A, Cruz-López O, Conejo-García A, Campos JM, Sánchez A, García MA, Marchal JA.
Ramírez A, et al. Among authors: marchal ja.
Oncotarget. 2014 Jun 15;5(11):3590-606. doi: 10.18632/oncotarget.1962.
Oncotarget. 2014.
PMID: 24946763
Free PMC article.